Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Cancer

RCC_650x450
March 21, 2019/Cancer/News & Insight

Understanding Rheumatologic Immune-Related Adverse Events in Genitourinary Cancers

Cases of myalgia and arthralgia after CPI

18-HRT-311-Valley-Health-CQD-Hero-650×428
March 20, 2019/Cancer

Echocardiographic Screening Likely Unnecessary in Some Long-Term Pediatric Stem Cell Transplant Survivors

New study stratifies cardiac risk in radiation- and anthracycline-exposed patients

Dr.-Martin-HoloLens_650x450

Use of Augmented Reality in Microwave Ablation for Liver Cancer

Clinical trial explores utility of HoloLens in percutaneous procedure

650×450-low-risk-prostate-cancers
March 14, 2019/Cancer

Active Surveillance a Reasonable Option in African-American Men with Low-Risk Prostate Cancer

Study sheds new light on the utility of watchful waiting

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ovarian-CA_650x450
March 13, 2019/Cancer

Researchers Create Tool to Help Predict Survival for Patients with Advanced Stage Recurrent Ovarian Cancer

Time to recurrence most predictive

IV medications
March 12, 2019/Cancer/Tumor Oncology

Three Treatment Modalities Emerge for Patients with Triple-Negative Breast Cancer

Immunotherapy, PARP inhibitors and a targeted therapy

breast-surgery_650x450

Nipple-Sparing Mastectomy Effective as a Preventive Treatment

The most comprehensive study to date of long-term outcomes and trends

HPV_650x450

Safe to Spare: Avoiding the Submandibular and Other Salivary Glands During Head and Neck Radiation Therapy

Should lower rates of xerostomia

650×450-prostate
March 5, 2019/Cancer

Study Demonstrates Association Between Urologic Oncology Fellowship Training and Diagnostic Yield on Prostate Biopsy

Advanced training is linked to positive biopsy findings

TIVO3_650x450
March 4, 2019/Cancer/Tumor Oncology

More Therapies to Consider for Advanced and Refractory Renal Cell Carcinoma

Results of two studies presented at 2019 ASCO GU

BackPage 69 of 88Next

Advertisement

Ad